RESULTS: During 42-day storage, human and canine
RBCs showed progressive increases in supernatant non-transferrin-bound iron, cell-free hemoglobin, base deficit, and lactate levels that were overall greater at 6 C and 4 C than at 2 C. Animals transfused with 7-day-old
RBCs had similar plasma cell-free hemoglobin and nontransferrin-bound iron levels at 1 to 72 hours for all three temperature conditions by chromium-51 recovery analysis. However, animals transfused with 35-day-old RBCs stored at higher temperatures developed plasma elevations in non-transferrin-bound iron and cell-free hemoglobin at 24 and 72 hours. Despite apparent impaired 35-day storage at 4 C and 6 C compared to 2 C, posttransfusion chromium-51 recovery at 24 hours was superior at higher temperatures. This finding was confounded by a preparation artifact related to an interaction between temperature and storage duration that leads to removal of fragile cells with repeated washing of the radiolabeled RBC test sample and renders the test sample unrepresentative of the stored unit.
CONCLUSIONS: RBCs stored at the lower bounds of the temperature range are less metabolically active and produce less anaerobic acidosis and hemolysis, leading to a more suitable transfusion product. The higher refrigeration temperatures are not optimal during extended RBC storage and may confound chromium viability studies.
S
torage conditions affect the quality of allogeneic red blood cells (RBCs) and the clinical response to transfusion. Storage quality can vary by preservative solution, type of container and filter, refrigeration temperature, and duration. The age of stored RBCs has recently been a focus for researchers. In the United States, the Food and Drug Administration (FDA) allows a maximum shelf-life of 42 days when using modern anticoagulantpreservative solutions 1 at refrigeration temperatures of 1-6 C, 2 although retrospective and experimental work has suggested greater adverse effects as transfused cells approach the 42-day expiration date. [3] [4] [5] The increased hemolysis after prolonged storage and release of cell-free hemoglobin (CFH) and non-transferrin-bound iron (NTBI) may increase transfusion risks in subgroups such as patients with invasive bacterial infections. 6 At present, prospective clinical trials have not demonstrated a clear survival benefit for patients who receive fresher blood, although trial arms have been limited to RBC storage for 7 to 10 days versus 18 to 22 days, and included few RBCs close to the 42-day limit. 3 Evidence to date has been insufficient to change storage guidelines. 3, 5, [7] [8] [9] A potential confounder for studies of storage duration is the refrigeration temperature. Neither retrospective studies nor clinical trials have separately considered whether cold storage temperature might impact RBC viability, especially at the extremes of storage duration. When compared to other factors affecting RBC quality, the range of temperature variation allowed during storage, which has not fundamentally changed in more than 70 years, 10 has received far less attention.
Because refrigeration is a key regulatory variable in RBC storage, administration, and transport, a reexamination of the effect of storage temperature with contemporary RBC storage practices is long overdue. Therefore, we undertook a detailed investigation of the effects of storage temperature on RBC viability, using ex vivo human and canine RBCs, and in vivo radiolabeled RBC transfusions into animals. We hypothesized that the lower bounds of the regulated storage temperature range would result in greater recovery of transfused RBCs and less hemolysis with release of potentially harmful by-products such as CFH and iron.
MATERIALS AND METHODS

Experimental design
This study was designed to examine the impact of varying the RBC storage temperature and duration within the recommended ranges used in the United States and Europe. Modern RBC anticoagulant-preservatives and state-of-theart refrigeration techniques were used.
In the first set of ex vivo experiments, human and canine RBCs were randomly assigned to a specific storage temperature for 6 weeks. Storage bag supernatant was sampled weekly during this 6-week period to examine indices of RBC hemolysis (CFH and NTBI) and quality of the storage milieu (base deficit and lactate levels). A detailed description of these experimental procedures and blood storage techniques can be found below and in the online Appendix S1 Details on Blood Banking Techniques, Animal Care, Chromium Studies, Laboratory Analysis and Statistical Method.
To correlate the findings of the ex vivo studies in an in vivo experimental setting, we used a well-described model of canine RBC transfusion to examine the effect of varying RBC storage temperature on hemolysis and RBC viability after transfusion. 11 12 such that blood from all donors was studied at all temperatures in random order. RBCs were stored using the AS-3 preservative-anticoagulant solution (Nutricel, Haemonetics Corporation) for 42 days at one of three randomized storage temperatures (2 C, 4 C, or 6 C).
All units were sampled serially for laboratory analysis on the day of donation and every 7 days over the 42-day storage period. Samples were analyzed for complete blood count, electrolyte panel, CFH, NTBI, lactate, and blood gas analysis. On Day 42, RBCs were sampled immediately after removal from the refrigerator, and then again after 2 and 4 hours of incubation on a rocker at room temperature. These two additional samplings simulate the clinical scenario where RBCs are transfused within the currently acceptable maximum range of 4 hours after removal from refrigeration.
Animal transfusion procedure
To minimize antigenic variability between samples and because a single donor canine could not safely provide sufficient RBCs for the four animals studied each week simultaneously, a pooled sample from eight donors was prepared. All RBC storage bags were treated under identical conditions according to FDA regulations. 2, 12, 14 One day prior to transfusion (Day 6 or Day 34), RBC bags were sampled for complete blood count, electrolyte panel, CFH, TBI, NTBI, lactate, and blood gas. Additionally, microbiological culture was performed to detect any bacterial contamination. At 7 or 35 days of storage, 4 units (2 each from a different refrigerator, determined randomly) were removed, and 20 mL/kg (equivalent to 2-4 RBC units for a human) were transfused into each animal. Any remaining volume was discarded.
For additional description of the experimental procedures and techniques in these three sets of experiments and statistical methods, see Appendixes S1 and S2, available as supporting information in the online version of this paper.
Study approval
All experiments were conducted after protocol approval (#CCM-17-01) by the Animal Care and Use Committee of the Clinical Center at the National Institutes of Health.
RESULTS
RBC storage at higher temperatures raises supernatant NTBI levels NTBI increased for canine RBCs stored under the alternating 2 C and 6 C refrigeration regimen (p < 0.0001), which did not differ from the cells maintained continuously at 2 C (p = 0.41) (Fig. 1D ).
RBC storage at higher temperatures raises supernatant CFH levels
Human RBCs experienced progressive increases in CFH over 42 days of storage at all storage temperatures (2 C: p = 0.0004; 4 C: p < 0.0001; 6 C: p < 0.0001) ( Fig. 2A ). There was a further progressive increase in CFH over 4 hours at room temperature, independent of previous storage temperature (all, p < 0.0001) (Fig. 2B ). There were no significant differences in the increases over 42 days and over 4 hours at room temperature in CFH levels at the different storage temperatures in Fig 
RBCs stored at higher temperatures have lower supernatant base excess and higher levels of lactate
Human RBCs exhibited a decrease in base excess over 42-day storage (all, p < 0.0001). The fall in base excess levels was significantly greater at 6 C versus 2 C (p < 0.0001) and at 4 C versus 2 C (p = 0.009) (Fig. 3A) . Lactate levels also progressively increased over 42-day storage at all temperatures (all, p < 0.0001) (Fig. 3B ). Although lactate levels were nominally increased at higher-temperature storage throughout the 42 days, there was no statistically significant rise in levels with higher temperatures. Canine RBCs also underwent a progressive fall in base excess at 2 C, 4 C, and 6 C (all, p < 0.0001), which was greater at 6 C (p < 0.0001) and 4 C (p = 0.03) than 2 C (Fig. 3C ). Progressively increased lactate levels were also seen at all temperatures (all p < 0.0001), with the increase again greater at 6 C than 2 C (p = 0.002) and 4 C than 2 C (p = 0.02) (Fig. 3D ).
Canine NTBI and TBI levels exhibit two peaks after transfusion with 35-day-old RBCs stored at 4 C and 6 C Studies were undertaken to correlate supernatant acidosis, hemolysis, lactate, NTBI, and CFH levels following storage with in vivo, posttransfusion values in animals. At 7 days of storage, serum NTBI was not significantly different for animals receiving RBCs stored at 2 C compared to 6 C at 0 to 72 hours after transfusion. NTBI was not significantly different from baseline at 24 or 48 hours for RBCs stored at either 2 C or 6 C. By 72 hours, NTBI levels were elevated compared to baseline in animals receiving RBCs stored at 6 C for 7 days (p = 0.001), but only a trend at 2 C (p = 0.07) ( with nonsignificant rises in mean NTBI levels at that same time point (Fig. 4A) . At 35 days, the changes in TBI levels over 72 hours mirror the findings for mean NTBI levels (Fig. 4D) . Cr RBC survival assays were performed in animals. After 7 days of storage, no significant difference in 51 Cr recovery was observed for animals transfused RBCs stored at 6 C and 2 C (Fig. 5A) . At 72 hours after transfusion, there was a substantial (though not statistically significant) decrease in 51 Cr recovery after transfusion with radiolabeled RBCs stored at 6 C (p = 0.07) (Fig. 5A) . 
DISCUSSION
During the past 50 years, few of the seminal studies advancing RBC storage practices have addressed how modern practices affect the optimal storage temperature. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] Storage temperature was examined in the late 1970s 25 during the development of modern preservative solutions. Similar to our findings, these studies showed that raising storage temperature from 2.5 to 5.5 C with modern storage solutions over 6 weeks increased lactate production and lowered pH. Some studies concluded that "temperature should be recognized as a potentially highly significant variable," 22 though others considered these differences small and of no practical importance. 25 The present study examines human and canine RBCs stored under modern conditions in precision-controlled refrigerators to maintain exact temperatures. We selected for study three temperatures at the bounds and midway within this range: 2 C, 4 C, and 6 C. At the higher storage temperatures of 4 C and 6 C, progressive elevations in NTBI and CFH were observed in the storage bag over time. Both human and animal RBCs stored at 2 C overall showed smaller or no increase in NTBI and CFH under the same conditions. During storage, decreases in base excess and increases in lactate levels were also observed at the higher temperatures. It is likely that increased RBC metabolic function at higher temperatures resulted in more acid accumulation in the storage container and poorer storage conditions, which in turn resulted in greater hemolysis. We also observed a paradoxically lower recovery of chromium-labeled RBCs following transfusion of RBCs stored at lower temperatures, which may be due to a survival bias caused when prolonged storage at higher temperatures selects against "weaker" RBCs. While small changes associated with increased metabolic activity can be seen after even short durations of storage, the effect requires weeks to develop a clinically detectable difference. In our animal model of transfusion, RBCs stored for just 7 days showed no difference in 51 Cr survival at 24 hours after transfusion, regardless of temperature. Although 24 hours is defined as the interval used for licensure, we observed at 48 and 72 hours that RBCs stored at 6 C showed progressively declining chromium survival not seen with RBCs stored at 2 C. This same phenomenon of delayed hemolysis over time was also seen after 35 days at higher cold-storage temperatures. The clinical consequences of delayed hemolysis with release of CFH and NTBI are unknown, but increased risks by promoting bacterial growth during infection or through nitric oxide scavenging worsening coronary syndromes, respectively, have been proposed. In contrast to 7-day-old RBCs, RBCs transfused after 35 days at 4 C and 6 C showed superior survival at 24, 48, and 72 hours when compared to RBCs stored at 2 C. The apparently improved recovery occurred despite the increased hemolysis in the storage bags after 35 days and the higher NTBI and CHF for 72 hours after transfusion. We attribute the discrepancy to a storage-induced artifact affecting the 51 Cr assay. We reported previously that washing RBCs after prolonged storage could result in hemolysis of the more vulnerable cells that would be sufficient to alter transfusion study outcomes. 27 The 51 Cr labeling process includes two washing steps and a room temperature incubation interval. Cells washed after 35-day storage at higher temperatures showed reduced total cell counts. We suspect that metabolic injury at higher-temperature cold storage preferentially injures the "weaker" cells in the storage bag.
These cells would be more susceptible to lysis during the washing steps. In that case, the cells that survive 51
Cr labeling represent a "stronger" cohort, not representative of the original cells in the container at the end of storage prior to transfusion. Supporting this hypothesis is the finding that more total cells remained after the labeling process in cells stored at 2 C.
These findings suggest that storage temperature may represent a previously unrecognized confounder for the standard chromium survival assay. 51 Cr studies of human RBCs, the interpretation of the radiolabeling assay for evaluating RBC storage quality will have to be reevaluated. Our studies of human and canine RBCs appear to indicate an interaction between storage time and temperature within the regulatory storage standards. The upper extreme of temperature (4-6 C) showed increased NTBI and CFH, both of which are potentially harmful to transfusion recipients. 6, 9, 11, 26 After transfusion of these RBCs into animals, we observed two peaks in serum NTBI and CHF. The initial peak in the first 24 hours could be attributed to substances transfused from the supernatant and rapid hemolysis of damaged donor cells. After return to normal levels over 24 to 48 hours, a second peak at 72 hours probably relates to delayed hemolysis of donor RBCs with less severe storage injury. As the study terminated at 72 hours, the persistence of the elevated NTBI and CFH is unknown. The clinical significance of delayed donor cell hemolysis is also uncertain, although it may represent an important secondary endpoint to consider when evaluating storage conditions. The effect of higher refrigeration temperature may be underestimated because the experimental paradigm did not consider additional factors thought to influence viability, such as the time in clinical practice that RBCs are kept not fully refrigerated prior to the initiation of transfusion. In addition, after collection many RBC units are kept at ambient temperatures for up to 24 hours before processing to obtain platelets, and then may be transported at 10 C from the collecting blood center and between hospitals for up to 24 hours. The use of blood warmers was likewise uninvestigated. These data suggest that storage temperature is particularly important for the survival of cells after protracted storage, noting that RBCs stored at alternating temperatures (between 2 C and 6 C every 12 hours over 42 days) were identical to RBCs stored strictly at 4 C.
Human and canine RBCs produced consistent storage temperature findings with one exception. Human RBCs showed no lowering of the of CFH elevations in the supernatant during prolonged storage at 2 C. In contrast, these cells had lower supernatant NTBI levels with prolonged storage at 2 C. Likewise, animal RBCs with prolonged storage at 2 C produced both lower CFH and NTBI levels in the supernatant and, after transfusion, lower plasma levels of both. We find no plausible mechanism by which prolonged storage at lower temperatures would have different effects on NTBI and CFH release for human RBCs but not for canine RBCs. We attribute this isolated CFH finding by exclusion to studying a small number (three) of human RBC units.
In conclusion, blood storage practice standards may not adequately account for an important interaction between storage time and temperatures that may confound chromium RBC viability testing and prove clinically relevant. At the upper of bounds of the refrigeration temperature range, lower RBC viability and increased hemolytic byproducts are seen at the end of the shelf life. Early and ongoing hemolysis within the storage bag and in vivo would result in shorter intervals between transfusions, the need for additional transfusions, and increased iron deposition for chronically transfused patients. The washing procedure for chromium labeling combined with higher temperature storage causes lysis of a cohort of cells, resulting in a test sample not representative of RBCs being transfused. Storage at refrigeration temperatures closer to 2 C may result in a better product for transfusion and more accurate for chromium RBC viability testing. Further studies are needed to determine the reproducibility of our findings in human volunteers and the magnitude of their clinical importance.
